Pathological and molecular evaluation of pancreatic neoplasms

Seminars in Oncology

Volumn 42, Issue 1, 2015, Pages 28-39

  Rishi, Arvind ^a   Goggins, Michael ^a   Wood, Laura D ^a   Hruban, Ralph H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; K RAS PROTEIN; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN;

ACINAR CELL CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CYSTIC NEOPLASM; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MUCINOUS CYSTIC NEOPLASM; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATIC NEUROENDOCRINE TUMOR; PANCREATOBLASTOMA; PRIORITY JOURNAL; TELOMERE; ANIMAL; CARCINOMA, PANCREATIC DUCTAL; GENETICS; HUMAN; MUTATION; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; TUMOR GENE;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; GENES, NEOPLASM; HUMANS; MUTATION; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS;

EID: 84923465208     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.12.004     Document Type: Review

References (114)

1. R. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA. Cancer J Clin 65 2015 5 29
2. R.H. Hruban, M.B. Pitman, and D.S. Klimstra Tumors of the pancreas 2007 American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology Washington, DC
3. P.C. Hermann, S.M. Trabulo, and B. Sainz Jr Multimodal treatment eliminates cancer stem cells and leads to long-term survival in primary human pancreatic cancer tissue xenografts PloS One 8 2013 e66371
4. C.E. Binkley, L. Zhang, and J.K. Greenson The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma Pancreas 29 2004 254 263
5. T. Furukawa, G. Klöppel, and N. Volkan Adsay Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study Virchows Arch Int J Pathol 447 2005 794 799
6. S.J. Murphy, S.N. Hart, and J.F. Lima Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor Gastroenterology 145 2013 1098 (109.e1)
7. M. Kanda, H. Matthaei, and J. Wu Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia Gastroenterology 142 2012 730 (-3.e9)
8. M. Kanda, Y. Sadakari, and M. Borges Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia Clin Gastroenterol Hepatol 11 2013 719 (730.e5)
9. R.H. Hruban, M. Goggins, and J. Parsons Progression model for pancreatic cancer Clin Cancer Res 6 2000 2969 2972
10. R.H. Hruban, N.V. Adsay, and J. Albores-Saavedra Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 2001 579 586
11. S. Jones, X. Zhang, and D.W. Parsons Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
12. A.V. Biankin, N. Waddell, and K.S. Kassahn Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes Nature 491 2012 399 405
13. M. Goggins, G.J. Offerhaus, and W. Hilgers Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+ Am J Pathol 152 1998 1501 1507
14. H. Ying, A.C. Kimmelman, and C.A. Lyssiotis Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism Cell 149 2012 656 670
15. A. Le, N.V. Rajeshkumar, and A. Maitra Conceptual framework for cutting the pancreatic cancer fuel supply Clin Cancer Res 18 2012 4285 4290
16. A. Le, C.R. Cooper, and A.M. Gouw Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression Proc Natl Acad Sci U S A 107 2010 2037 2042
17. J. Son, C.A. Lyssiotis, and H. Ying Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway Nature 496 2013 101 105
18. G.M. DeNicola, F.A. Karreth, and T.J. Humpton Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis Nature 475 2011 106 109
19. C. Commisso, S.M. Davidson, and R.G. Soydaner-Azeloglu Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells Nature 497 2013 633 637
20. S. Yang, X. Wang, and G. Contino Pancreatic cancers require autophagy for tumor growth Genes Dev 25 2011 717 729
21. S.R. Hingorani, E.F. Petricoin, and A. Maitra Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 2003 437 450
22. R. Shen, Q. Wang, and S. Cheng The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models Cancer Lett 339 2013 135 143
23. M.A. Collins, F. Bednar, and Y. Zhang Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice J Clin Invest 122 2012 639 653
24. D.M. Berman, S.S. Karhadkar, and A. Maitra Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours Nature 425 2003 846 851
25. R.L. Yauch, S.E. Gould, and S.J. Scales A paracrine requirement for hedgehog signalling in cancer Nature 455 2008 406 410
26. L.D. Mills, Y. Zhang, and R.J. Marler Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation J Biol Chem 288 2013 11786 11794
27. C.E. Clark, S.R. Hingorani, and R. Mick Dynamics of the immune reaction to pancreatic cancer from inception to invasion Cancer Res 67 2007 9518 9527
28. I.M. Stromnes, J.S. Brockenbrough, and K. Izeradjene Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity Gut 63 2014 1769 1781
29. D.T. Le, and E.M. Jaffee Harnessing immune responses in the tumor microenvironment: all signals needed Clin Cancer Res 19 2013 6061 6063
30. N.S. Pellegata, F. Sessa, and B. Renault K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions Cancer Res 54 1994 1556 1560
31. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat Med 10 2004 789 799
32. A. Maitra, and R.H. Hruban Pancreatic cancer Annu Rev Pathol 3 2008 157 188
33. N.E. Sharpless INK4a/ARF: a multifunctional tumor suppressor locus Mutat Res 576 2005 22 38
34. R.E. Wilentz, J. Geradts, and R. Maynard Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression Cancer Res 58 1998 4740 4744
35. C. Caldas, S.A. Hahn, and Costa LT da Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27 32
36. S.A. Hahn, M. Schutte, and A.T. Hoque DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 1996 350 353
37. C.A. Iacobuzio-Donahue, J. Song, and G. Parmiagiani Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors Clin Cancer Res 10 2004 1597 1604
38. R.E. Wilentz, G.H. Su, and J.L. Dai Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation Am J Pathol 156 2000 37 43
39. M. Tascilar, H.G. Skinner, and C. Rosty The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma Clin Cancer Res 7 2001 4115 4121
40. C.A. Iacobuzio-Donahue, B. Fu, and S. Yachida DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J Clin Oncol 27 2009 1806 1813
41. A. Blackford, O.K. Serrano, and C.L. Wolfgang SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer Clin Cancer Res 15 2009 4674 4679
42. N.T. Heek, A.K. van, Meeker, and S.E. Kern Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia Am J Pathol 161 2002 1541 1547
43. S.-M. Hong, C.M. Heaphy, and C. Shi Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias Mod Pathol 24 2011 256 266
44. N.V. Adsay, K. Merati, and A. Andea The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis Mod Pathol 15 2002 1087 1095
45. Molin M Dal, H. Matthaei, and J. Wu Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas Ann Surg Oncol 20 2013 3802 3808
46. G.A. Poultsides, S. Reddy, and J.L. Cameron Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas Ann Surg 251 2010 470 476
47. J. Wu, H. Matthaei, and A. Maitra Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development Sci Transl Med 3 2011 92ra66
48. E.S. Calhoun, J.B. Jones, and R. Ashfaq BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets Am J Pathol 163 2003 1255 1260
49. R.E. Wilentz, M. Goggins, and M. Redston Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity Am J Pathol 156 2000 1641 1651
50. J.M. Winter, A.H. Ting, and F. Vilardell Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer Clin Cancer Res 14 2008 412 418
51. S.-M. Hong, A. Li, and K. Olino Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas Mod Pathol 24 2011 1237 1247
52. W. Kimura, H. Nagai, and A. Kuroda Analysis of small cystic lesions of the pancreas Int J Pancreatol 18 1995 197 206
53. X.-M. Zhang, D.G. Mitchell, and M. Dohke Pancreatic cysts: depiction on single-shot fast spin-echo MR images Radiology 223 2002 547 553
54. M.I. Canto, R.H. Hruban, and E.K. Fishman Frequent detection of pancreatic lesions in asymptomatic high-risk individuals Gastroenterology 142 2012 796 804
55. T.A. Laffan, K.M. Horton, and A.P. Klein Prevalence of unsuspected pancreatic cysts on MDCT AJR Am J Roentgenol 191 2008 802 807
56. Jong K de, C.Y. Nio, and J.J. Hermans High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations Clin Gastroenterol Hepatol 8 2010 806 811
57. S.T. Chari, D. Yadav, and T.C. Smyrk Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas Gastroenterology 123 2002 1500 1507
58. M. Tanaka, C. Fernández-del Castillo, and V. Adsay International consensus guidelines. 2012 for the management of IPMN and MCN of the pancreas Pancreatol 12 2012 183 197
59. N.V. Adsay, C. Pierson, and F. Sarkar Colloid (mucinous noncystic) carcinoma of the pancreas Am J Surg Pathol 25 2001 26 42
60. T.A. Sohn, C.J. Yeo, and J.L. Cameron Intraductal papillary mucinous neoplasms of the pancreas: an updated experience Ann Surg 239 2004 788 797
61. N.V. Adsay, K.C. Conlon, and S.Y. Zee Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients Cancer 94 2002 62 77
62. J. Wu, Y. Jiao, and Molin M Dal Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways Proc Natl Acad Sci U S A 108 2011 21188 21193
63. M. Kitago, M. Ueda, and K. Aiura Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas Int J Cancer 110 2004 177 182
64. E. Amato, M.D. Molin, and A. Mafficini Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas J Pathol 233 2014 217 227
65. K. Satoh, T. Shimosegawa, and S. Moriizumi K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas Pancreas 12 1996 362 368
66. N. Lubezky, M. Ben-Haim, and S. Marmor High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN) J. Gastrointest Surg 15 2011 503 511
67. F. Schönleben, W. Qiu, and H.E. Remotti PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas Langenbecks Arch Surg 393 2008 289 296
68. H. Kawahira, S. Kobayashi, and K. Kaneko p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy Hepatogastroenterology 47 2000 973 977
69. B. Chadwick, C. Willmore-Payne, and S. Tripp Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas Appl Immunohistochem Mol Morphol 17 2009 31 39
70. C.A. Iacobuzio-Donahue, D.S. Klimstra, and N.V. Adsay Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas Am J Pathol 157 2000 755 761
71. L.S. Weinstein, J. Liu, and A. Sakamoto Minireview: GNAS: normal and abnormal functions Endocrinology 145 2004 5459 5464
72. S. Gaujoux, S. Salenave, and M. Ronot Hepatobiliary and pancreatic neoplasms in patients with McCune-Albright syndrome J Clin Endocrinol Metab 99 2014 E97-101
73. M. Kanda, S. Knight, and M. Topazian Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts Gut 62 2013 1024 1033
74. K. Shinada, T. Tsukiyama, and T. Sho RNF43 interacts with NEDL1 and regulates p53-mediated transcription Biochem Biophys Res Commun 404 2011 143 147
75. X. Jiang, H.-X. Hao, and J.D. Growney Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma Proc Natl Acad Sci U S A 110 2013 12649 12654
76. B.-K. Koo, M. Spit, and I. Jordens Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors Nature 488 2012 665 669
77. A. Yanagisawa, Y. Kato, and K. Ohtake c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas Jpn J Cancer Res Gann 82 1991 1057 1060
78. R.E. Jimenez, A.L. Warshaw, and K. Z'graggen Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy Ann Surg 230 1999 501 509
79. C. Sorio, P. Capelli, and D. Lissandrini Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion Virchows Arch Int J Pathol 446 2005 239 245
80. L.H. Tang, H. Aydin, and M.F. Brennan Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases Am J Surg Pathol 29 2005 512 519
81. S. Reddy, J.L. Cameron, and J. Scudiere Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series J Am Coll Surg 208 2009 950 957
82. Z. Meriden, C. Shi, and B.H. Edil Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis Am J Surg Pathol 35 2011 981 988
83. Y. Guo, F. Yuan, and H. Deng Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas Am J Surg Pathol 35 2011 799 806
84. S.A. Kim, M.-S. Kim, and M.-S. Kim Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential Hum Pathol 45 2014 166 174
85. S.C. Abraham, D.S. Klimstra, and R.E. Wilentz Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations Am J Pathol 160 2002 1361 1369
86. S. Min Kim, C.D. Sun, and K.C. Park Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas J Surg Oncol 94 2006 418 425
87. Y. Tanaka, K. Kato, and K. Notohara Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm Cancer Res 61 2001 8401 8404
88. R. Chetty, and S. Serra Loss of expression of E-cadherin in solid pseudopapillary tumors of the pancreas Pancreas 38 2009 338
89. V. Audard, C. Cavard, and H. Richa Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas Pancreas 36 2008 80 83
90. J.C. Yao, M.P. Eisner, and C. Leary Population-based study of islet cell carcinoma Ann Surg Oncol 14 2007 3492 3500
91. M. Falconi, U. Plockinger, and D.J. Kwekkeboom Well-differentiated pancreatic nonfunctioning tumors/carcinoma Neuroendocrinology 84 2006 196 211
92. World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.
93. C.M. McCall, C. Shi, and T.C. Cornish Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate Am J Surg Pathol 37 2013 1671 1677
94. Y. Jiao, C. Shi, and B.H. Edil DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors Science 331 2011 1199 1203
95. H.C. Chiang, T.M. O'Dorisio, and S.C. Huang Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome Gastroenterology 99 1990 1565 1575
96. Y.M.H. Jonkers, F.C.S. Ramaekers, and E.J.M. Speel Molecular alterations during insulinoma tumorigenesis Biochim Biophys Acta 1775 2007 313 332
97. O. Hessman, D. Lindberg, and A. Einarsson Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors Genes Chromosomes Cancer 26 1999 258 264
98. C.M. Heaphy, R.F. Wilde, and Y. de, Jiao Altered telomeres in tumors with ATRX and DAXX mutations Science 333 2011 425
99. Wilde RF de, C.M. Heaphy, and A. Maitra Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors Mod Pathol 25 2012 1033 1039
100. J.C. Yao, M.H. Shah, and T. Ito Everolimus for advanced pancreatic neuroendocrine tumors N Engl J Med 364 2011 514 523
101. D. Speisky, A. Duces, and I. Bièche Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients Clin Cancer Res 18 2012 2838 2849
102. A.M. Schmitt, S. Schmid, and T. Rudolph VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors Endocr Relat Cancer 16 2009 1219 1227
103. S. Rosa, V. La, Adsay, and L. Albarello Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers Am J Surg Pathol 36 2012 1782 1795
104. D.S. Klimstra, C.S. Heffess, and J.E. Oertel Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases Am J Surg Pathol 16 1992 815 837
105. Y. Jiao, R. Yonescu, and G.J.A. Offerhaus Whole-exome sequencing of pancreatic neoplasms with acinar differentiation J Pathol 232 2014 428 435
106. S.C. Abraham, T.-T. Wu, and R.H. Hruban Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway Am J Pathol 160 2002 953 962
107. M.C. Villarroel, N.V. Rajeshkumar, and I. Garrido-Laguna Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer Mol Cancer Ther 10 2011 3 8
108. C.T. Williamson, E. Kubota, and J.D. Hamill Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53 EMBO Mol Med 4 2012 515 527
109. P.B. Chapman, A. Hauschild, and C. Robert Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 2011 2507 2516
110. J. Chmielecki, K.E. Hutchinson, and G.M. Frampton Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes Cancer Discov 4 2014 1398 1405
111. B. Salman, G. Brat, and Y.-S. Yoon The diagnosis and surgical treatment of pancreatoblastoma in adults: a case series and review of the literature J Gastrointest Surg 17 2013 2153 2161
112. E. Bien, J. Godzinski, and P. Dall'igna Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT) Eur J Cancer Oxf Engl 47 2011 2347 2352
113. H. Esfahani, E. Olad, and A. Dehghan Infantile extrapancreatic pancreatoblastoma: a report on a rare infantile abdominal mass J Pediatr Hematol Oncol 36 2013 241 245
114. S.C. Abraham, T.T. Wu, and D.S. Klimstra Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p Am J Pathol 159 2001 1619 1627